Randomized controlled trial of individualized dialysate cooling for cardiac protection in hemodialysis patients

Clinical Journal of the American Society of Nephrology

Volumn 10, Issue 8, 2015, Pages 1408-1417

  Odudu, Aghogho ^a,b,c   Eldehni, Mohamed Tarek ^b,c   McCann, Gerry P ^d,e   McIntyre, ChrIstopher W ^f  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c ROYAL DERBY HOSPITAL   (United Kingdom)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

^e The National Institute for Health Research Health Protection Research Unit in Blood Borne and Sexually Transmitted Infections at University College London in partnership with UK Health Security Agency   (United Kingdom)

^f WESTERN UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AORTIC DISTENSIBILITY; ARTICLE; BLOOD PUMP SPEED; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DIALYSATE COOLING; FEMALE; FLOW RATE; HEART DILATATION; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART PROTECTION; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UROLOGICAL PROCEDURE; ADVERSE EFFECTS; AGED; AORTA; ARTERIAL STIFFNESS; CARDIOMYOPATHIES; CLINICAL TRIAL; COLD; ENGLAND; HEART CONTRACTION; HEART STROKE VOLUME; MIDDLE AGED; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; VERY ELDERLY;

HEMODIALYSIS FLUID;

ADULT; AGED; AGED, 80 AND OVER; AORTA; CARDIOMYOPATHIES; COLD TEMPERATURE; ENGLAND; FEMALE; HEMODIALYSIS SOLUTIONS; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VASCULAR STIFFNESS; VENTRICULAR FUNCTION, LEFT;

EID: 84938901027     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00200115     Document Type: Article

References (45)

1. GrossML, Ritz E: Hypertrophy and fibrosis in the cardiomyopathy of uremia-beyond coronary heart disease. Semin Dial 21: 308- 318, 2008
2. Breidthardt T, McIntyre CW: Dialysis-induced myocardial stunning: the other side of the cardiorenal syndrome. Rev Cardiovasc Med 12: 13-20, 2011
3. Burton JO, Jefferies HJ, Selby NM, McIntyre CW: Hemodialysisinduced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol 4: 1925-1931, 2009
4. Burton JO, Jefferies HJ, Selby NM, McIntyre CW: Hemodialysisinduced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol 4: 914-920, 2009
5. Assa S, Hummel YM, Voors AA, Kuipers J,Westerhuis R, de Jong PE, Franssen CF: Hemodialysis-induced regional left ventricular systolic dysfunction: prevalence, patient and dialysis treatmentrelated factors, and prognostic significance. Clin J Am Soc Nephrol 7: 1615-1623, 2012
6. MaggioreQ, Pizzarelli F, Zoccali C, Sisca S,Nicolò F, Parlongo S: Effect of extracorporeal blood cooling on dialytic arterial hypotension. Proc Eur Dial Transplant Assoc 18: 597-602, 1981
7. Selby NM, McIntyre CW: A systematic review of the clinical effects of reducing dialysate fluid temperature. Nephrol Dial Transplant 21: 1883-1898, 2006
8. Jefferies HJ, Virk B, Schiller B, Moran J, McIntyre CW: Frequent hemodialysis schedules are associated with reduced levels of dialysis-induced cardiac injury (myocardial stunning). Clin J Am Soc Nephrol 6: 1326-1332, 2011
9. Chesterton LJ, Selby NM, Burton JO, McIntyre CW: Cool dialysate reduces asymptomatic intradialytic hypotension and increases baroreflex variability. Hemodial Int 13: 189-196, 2009
10. Jefferies HJ, Burton JO, McIntyre CW: Individualised dialysate temperature improves intradialytic haemodynamics and abrogates haemodialysis-induced myocardial stunning, without compromising tolerability. Blood Purif 32: 63-68, 2011
11. Eldehni MT,Odudu A, McIntyre CW: Randomized clinical trial of dialysate cooling and effects on brain white matter. J Am Soc Nephrol 26: 957-965, 2015
12. Odudu A, Eldehni MT, Fakis A, McIntyre CW: Rationale and design of a multi-centre randomised controlled trial of individualised cooled dialysate to prevent left ventricular systolic dysfunction in haemodialysis patients. BMC Nephrol 13: 45, 2012
13. Movilli E, Cancarini GC, Cassamali S, Camerini C, Brunori G, Maffei C, Maiorca R: Inter-dialytic variations in blood volume and total body water in uraemic patients treated by dialysis. Nephrol Dial Transplant 19: 185-189, 2004
14. Sheen V, Bhalla V, Tulua-Tata A, Bhalla MA, Weiss D, Chiu A, Abdeen O, Mullaney S, Maisel A: The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal disease. Am Heart J 153: e1-e5, e5, 2007
15. Hudsmith LE, Petersen SE, Francis JM, Robson MD, Neubauer S: Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson 7: 775-782, 2005
16. Fü rstenberg A, Davenport A: Comparison of multifrequency bioelectrical impedance analysis and dual-energy X-ray absorptiometry assessments in outpatient hemodialysis patients. Am J Kidney Dis 57: 123-129, 2011
17. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gómez JM, Heitmann BL, Kent-Smith L, Melchior JC, Pirlich M, Scharfetter H, Schols AM, Pichard C; Composition of the ESPEN Working Group: Bioelectrical impedance analysis-part I: review of principles and methods. Clin Nutr 23: 1226-1243, 2004
18. Mosteller RD: Simplified calculation of body-surface area. N Engl J Med 317: 1098, 1987
19. Shehata ML, Cheng S, Osman NF, Bluemke DA, Lima JA: Myocardial tissue tagging with cardiovascular magnetic resonance. J Cardiovasc Magn Reson 11: 55, 2009
20. Garot J, Bluemke DA, Osman NF, Rochitte CE, McVeigh ER, Zerhouni EA, Prince JL, Lima JA: Fast determination of regional myocardial strain fields from tagged cardiac images using harmonic phase MRI. Circulation 101: 981-988, 2000
21. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging: Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105: 539-542, 2002
22. Maroules CD, Khera A, Ayers C, Goel A, Peshock RM, Abbara S, King KS: Cardiovascular outcome associations among cardiovascular magnetic resonance measures of arterial stiffness: the Dallas heart study. J Cardiovasc Magn Reson 16: 33, 2014
23. Bramwell JC, Hill AV: Velocity of transmission of the pulse wave and elasticity of arteries. Lancet 1: 891-892, 1922
24. Šidák Z: Rectangular confidence regions for the means of multivariate normal distributions. J AmStat Assoc 62: 626-633, 1967
25. White IR, Carlin JB: Bias and efficiency of multiple imputation compared with complete-case analysis for missing covariate values. Stat Med 29: 2920-2931, 2010
26. Komajda M, Carson PE, Hetzel S, McKelvie R, McMurray J, Ptaszynska A, ZileMR,DemetsD, Massie BM: Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE). Circ Heart Fail 4: 27-35, 2011
27. Bellenger NG, Davies LC, Francis JM, Coats AJ, Pennell DJ: Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2: 271-278, 2000
28. London GM, Pannier B, Guerin AP, Blacher J,Marchais SJ, Darne B, Metivier F, Adda H, Safar ME: Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J AmSoc Nephrol 12: 2759- 2767, 2001
29. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Stancanelli B, Cataliotti A, Malatino LS: Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int 65: 1492- 1498, 2004
30. Liu YW, Su CT, Sung JM,Wang SP, Su YR, Yang CS, Tsai LM, Chen JH, Tsai WC: Association of left ventricular longitudinal strain with mortality among stable hemodialysis patients with preserved left ventricular ejection fraction. Clin J Am Soc Nephrol 8: 1564-1574, 2013
31. Iwabuchi Y, Ogawa T, Inoue T, Otsuka K, Nitta K: Elevated E/E' predicts cardiovascular events in hemodialysis patients with preserved systolic function. Intern Med 51: 155-160, 2012
32. GuerinAP, Blacher J, PannierB,Marchais SJ, SafarME, LondonGM: Impact of aortic stiffness attenuation on survival of patients in endstage renal failure. Circulation 103: 987-992, 2001
33. Cice G, Ferrara L, D'Andrea A, D'Isa S, Di Benedetto A, Cittadini A, Russo PE, Golino P, Calabrò R: Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial. J Am Coll Cardiol 41: 1438- 1444, 2003
34. Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, Daugirdas JT, Kotanko P, Larive B, Levin NW, Mehta RL, Rocco M, Sanz J, Yang PC, Rajagopalan S; Frequent Hemodialysis Network Trial Group: Effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling. Clin J Am Soc Nephrol 8: 2106-2116, 2013
35. Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS; FHN Trial Group: In-center hemodialysis six times perweek versus three times perweek.NEngl J Med 363: 2287-2300, 2010
36. Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, Daugirdas JT, Kotanko P, Larive B, Levin NW, Mehta RL, Rocco M, Sanz J, Schiller BM, Yang PC, Rajagopalan S; Frequent Hemodialysis Network (FHN) Trial Group: Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials. Circ Cardiovasc Imaging 5: 251-261, 2012
37. Kehat I, Molkentin JD: Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation 122: 2727-2735, 2010
38. Glassock RJ, Pecoits-Filho R, Barberato SH: Left ventricular mass in chronic kidney disease and ESRD. Clin J Am Soc Nephrol 4 [Suppl 1]: S79-S91, 2009
39. Shivalkar B, Flameng W, Szilard M, Pislaru S, Borgers M, Vanhaecke J: Repeated stunning precedes myocardial hibernation in progressive multiple coronary artery obstruction. J Am Coll Cardiol 34: 2126-2136, 1999
40. Selby NM, Burton JO, Chesterton LJ, McIntyre CW: Dialysisinduced regional left ventricular dysfunction is ameliorated by cooling the dialysate. Clin J Am Soc Nephrol 1: 1216-1225, 2006
41. Tissier R, Ghaleh B, Cohen MV, Downey JM, Berdeaux A: Myocardial protection with mild hypothermia. Cardiovasc Res 94: 217-225, 2012
42. Watanabe H, Ohtsuka S, Kakihana M, Sugishita Y: Coronary circulation in dogs with an experimental decrease in aortic compliance. J Am Coll Cardiol 21: 1497-1506, 1993
43. Niizuma S, Takiuchi S, Okada S, Horio T, Kamide K, Nakata H, Yoshihara F, Nakamura S, Kawano Y, Nakahama H, Iwanaga Y, Nakatani S: Decreased coronary flow reserve in haemodialysis patients. Nephrol Dial Transplant 23: 2324-2328, 2008
44. Bouthier JD, De Luca N, Safar ME, Simon AC: Cardiac hypertrophy and arterial distensibility in essential hypertension. Am Heart J 109: 1345-1352, 1985
45. Swoboda PP, Larghat A, Zaman A, Fairbairn TA, Motwani M, Greenwood JP, Plein S: Reproducibility ofmyocardial strain and left ventricular twist measured using complementary spatial modulation of magnetization. J Magn Reson Imaging 39: 887-894, 2014